Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Interest Expense

Cost of servicing the company's debt during the period.

Spectral Medical Inc.TSX: EDT.TO

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense grows, but more slowly than its trailing trend

Q1 FY2026 interest expense of CA$1.6M rose 47.7% year over year, behind the +52.7% change in trailing-twelve-month interest expense. Sequentially, it rose 3.8% from the prior quarter. Over 3 fiscal years it compounded at +208.4% a year.

Context

  • Interest expense amounted to 211.5% of revenue in FY2025, up 72.5 pp from a year earlier.
  • Interest expense increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +47.7% toward the trailing-twelve-month pace of +52.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.6M+3.8% QoQ
Last fiscal yearDec 2025
CA$5.16M+62.5% YoY
LTMMar 2026
CA$5.68M+52.7% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+47.7%——
1 year+62.5%——
3-year CAGR+208.4%——
5-year CAGR——
10-year CAGR——

Interest Expense history

CAD · from the income statement

Latest · FY2025
5.16M CAD
Year-over-year change
+62.5%
4-year CAGR
+268.5%

Interest Expense vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +52.7% is the highest of 8, against a peer median of -57.9%.
  • Interest expense amounts to 205.8% of revenue for EDT.TO, versus a peer median of 2.4%.
EDT.TO Competitors
Interest Expense for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$41.67M CAD-44.1%-32.9%13.4%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$5.82M CAD-30.8%-64.2%1.8%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$5.68M CAD+52.7%+208.4%205.8%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$3.28M CAD-10.9%+146.6%4.9%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$1.53M USD-57.9%+30.7%3.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$505.84K USD-61.3%—1.0%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%——
PRN.TOProfound Medical Corp.LTM Mar 2026$0 USD-100.0%—0.0%
Peer median (excluding EDT.TO) —-57.9%-1.1%2.4%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.